Sabra Healthcare REIT (NASDAQ:SBRA) Updates FY 2026 Earnings Guidance

Sabra Healthcare REIT (NASDAQ:SBRA) updated its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 1.530-1.550 for the period, compared to the consensus earnings per share estimate of 1.500. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on SBRA shares. Barclays started coverage on Sabra Healthcare REIT in a report on Tuesday, July 7th. They issued an “overweight” rating and a $21.00 price objective on the stock. Cantor Fitzgerald raised their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. UBS Group set a $25.00 target price on shares of Sabra Healthcare REIT in a research note on Wednesday. Citizens Jmp increased their price target on Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a research report on Wednesday. Finally, Raymond James Financial started coverage on Sabra Healthcare REIT in a report on Wednesday, June 17th. They issued an “underperform” rating for the company. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $22.25.

Sabra Healthcare REIT Price Performance

Shares of SBRA opened at $21.98 on Thursday. Sabra Healthcare REIT has a 1 year low of $17.17 and a 1 year high of $22.55. The stock has a market cap of $5.54 billion, a P/E ratio of 34.89, a price-to-earnings-growth ratio of 1.64 and a beta of 0.65. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The stock’s 50-day moving average price is $19.63 and its two-hundred day moving average price is $19.80.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same quarter in the prior year, the company earned $0.37 EPS. The company’s revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities analysts predict that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were given a $0.30 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.5%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 190.48%.

Institutional Investors Weigh In On Sabra Healthcare REIT

Several hedge funds and other institutional investors have recently modified their holdings of the company. Smartleaf Asset Management LLC raised its position in Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares during the period. Danske Bank A S purchased a new position in Sabra Healthcare REIT in the 3rd quarter worth approximately $30,000. Larson Financial Group LLC grew its position in Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 553 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Sabra Healthcare REIT by 150.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 1,536 shares during the last quarter. Finally, Quarry LP purchased a new position in shares of Sabra Healthcare REIT during the third quarter worth approximately $48,000. Institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.